Business Context and Reporting Period
Company: Redhill Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 24, 2021
Context: This filing serves as a notification to the SEC regarding an upcoming event. It incorporates by reference a press release announcing that the company will host a webcast on November 30, 2021, to present its Third Quarter 2021 financial results and operational highlights.
Key Financial Metrics
The filing text does not provide specific financial data. It acts as a procedural notice and does not contain revenue, profit, cash flow, margins, debt, or liquidity figures for the period.
Material Changes
No material changes to financial performance or operations are detailed in this specific document. The filing solely announces the scheduling of a future presentation to discuss Q3 2021 results.
Guidance, Outlook, and Management Commentary
Upcoming Event: Management plans to discuss Third Quarter 2021 financial results and operational highlights during a webcast on November 30, 2021.
Registration Statements: The report is incorporated by reference into multiple active Registration Statements on Form S-8 and Form F-3 filed between 2013 and 2021.
Investor Verification Checklist
- Verify the date and time of the Third Quarter 2021 webcast (announced as November 30, 2021).
- Locate the actual press release (Exhibit 99.1) referenced in the filing for any preliminary operational updates.
- Review the subsequent Q3 2021 earnings release or 20-F filing for actual financial metrics, as they are not included in this Form 6-K.
- Confirm the status of the referenced Registration Statements (Form S-8 and F-3) for potential capital raising activities.